Showing results (1571-1580 of 1,710) with videos related to

Sort By:
Pageof 171
NPJ Breast Cancer|May 14, 2025
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantificationKristin Galas, Moritz Gleitsmann, Julia Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical TrialsPaul Jank, Thomas Karn, Marion van Mackelenbergh, et al.
EMBO Molecular Medicine|May 17, 2021
uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophilsBernd Uhl, Laura A Mittmann, Julian Dominik, et al.
Clinical Epigenetics|November 10, 2024
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sitesTeodor G Calina, Eilís Perez, Elena Grafenhorst, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 2, 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working groupCarsten Denkert, Stephan Wienert, Audrey Poterie, et al.
Pediatric Neurology|June 4, 2023
Rehabilitation Outcomes in Children With Acute Flaccid Myelitis From 2014 to 2019: A Multicenter Retrospective ReviewDiana L Marchese, Keith Feldman, Clarice Sinn, et al.
Diabetes|November 26, 2020
CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not NephropathyJessy Chen, Thomas Fleming, Sylvia Katz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2019
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo studyS Loibl, M Untch, N Burchardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto TrialPeter A Fasching, Christopher Szeto, Carsten Denkert, et al.
The Journal of Infectious Diseases|October 14, 2017
Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective StudyYoung Chang, Won Hyeok Choe, Dong Hyun Sinn, et al.
Pageof 171